Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis (AST-MOMA)
This study is currently recruiting participants.
Verified October 2016 by Joerg Henes, University Hospital Tuebingen
University Hospital Tuebingen
Information provided by (Responsible Party):
Joerg Henes, University Hospital Tuebingen
First received: July 1, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||September 2020|
|Estimated Primary Completion Date:||September 2018 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Henes JC, Koetter I, Horger M, Schmalzing M, Mueller K, Eick C, Bauer A, Vogel W, Kanz L. Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations. Rheumatology (Oxford). 2014 May;53(5):919-22. doi: 10.1093/rheumatology/ket464. Epub 2014 Jan 22.